Skip to main content
Clinical Trials/CTRI/2020/12/029744
CTRI/2020/12/029744
Not yet recruiting
未知

Comparison of the risk of serious adverse outcomes and clinical, laboratory and radiological characteristics in stable patients hospitalized with COVID 19 divided by co morbidity status

Max Smart Super Speciality Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Max Smart Super Speciality Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients testing positive for SARSCoV2 by rRTpcr on a nasopharyngeal or oro pharyngeal swab
  • Hemodynamically stable patients getting admitted to ward
  • Able and willing to provide informed consent

Exclusion Criteria

  • Patients who meet any of the following criteria:
  • 1\.Critically ill patients defined as those
  • a.Requiring ICU admission
  • b.Requiring mech ventilation
  • c.Radiographic imaging with severe bilateral ground glass opacities or consol\-idation
  • d.ARDS with PaO2/FiO2 300mm Hg or less
  • e.Septic Shock requiring vasopressors
  • f.Altered consciousness
  • g.Multi organ failure as evidenced by CrCL \<30 ml/min or receiving HD, CVVH or ALT \> 5x upper limit of normal
  • 2\. Patients not giving informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials